Research and development product storage and shipping
Active Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,889,750
Award facts
- Opportunity
-
- Preclinical and translational vaccine development for HIV and other candidate agents Pre-Solicitation · 75N93019R00023 · Posted Mar 26, 2020
- Contract value 73% obligated
-
- $2,889,750.00 Current, with exercised options
- $3,960,926.00 Potential, with all options
- Completion date 70% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27715, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $518,876 | |
| Change Order | -$168,068 | |
| Exercise an Option | $672,207 | |
| Exercise an Option | $634,514 | |
| Exercise an Option | $616,716 | |
| Original award | $615,505 |
About this award
Duke University's Office of Research Administration was awarded a delivery order contract by the National Institute of Allergy and Infectious Diseases (NIAID) for research and development product storage and shipping support related to preclinical and translational vaccine development for HIV and other candidate agents. The contract, awarded on December 1, 2021, carries a ceiling value of approximately $3.96 million and extends through November 30, 2028. This is a cost-plus-no-fee delivery order issued under the parent indefinite delivery/indefinite quantity (IDIQ) contract titled "Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents." No set-aside designation was applied to this competitive award, which will be performed in Durham, North Carolina.
The contract represents part of Duke University's broader engagement with NIAID on vaccine development initiatives. Duke's Office of Research Administration has established significant federal contracting and grant relationships across multiple National Institutes of Health components and other agencies, with demonstrated expertise in complex research programs including clinical trials infrastructure, biomedical research support, and infectious disease studies. This delivery order specifically supports the logistical requirements for vaccine research and development activities, positioning Duke's research capabilities to advance NIAID's vaccine development mission for HIV and emerging infectious disease threats.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2021.
How much is contract 75N93022F00001 worth?
The government has obligated $2,889,750 on 75N93022F00001. Its potential value, with all options, is $3,960,926.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93022D00003, an indefinite delivery contract, on Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award